Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-002-1
CAS number: 102-06-7
study evaluates DPG for its ability to induce forward mutation in the
L5178Y TK+/- mouse lymphoma cell line, as assessed by colony growth in
the presence of 5-bromo-2'-deoxyuridine (BrdU). DPG did not induce a
significant increase in mutations at the TK locus in L5178Y mouse
lymphoma cells at applied concentrations of 16.4 to 188.0 ug/ml without
activation and at 32.8 to 525 ug/ml with microsomal activation. These
concentration ranges included highly toxic treatments. Therefore, the
test compound is considered to be inactive in the Mouse Lymphoma Forward
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Siekdami užtikrinti, kad būtų patogu naudotis mūsų svetaine, jos tinklapiuose naudojame slapukus.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again